Chemoendocrine therapy shows a greater negative association with patient-reported cognitive decline than endocrine therapy ...
The Canadian Press on MSN
Companies can make generic Ozempic as of next week, but don't expect to get it soon
Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug Ozempic as of next week, ...
CORT's shares plunge after the FDA issues a CRL to relacorilant's new drug application for treating patients with hypercortisolism.
Wellbeing Magazine on MSN
Best supplements to balance hormones: Your pick for 2026
The issues concerning the hormone balance have a great impact on the general well-being, the level of energy, the mood ...
Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.
Breakfast affects total daily energy intake, blood sugar levels, and overall body weight regulation. In South Asian ...
US officials have approved a daily pill version of Novo Nordisk’s injectable obesity drug Wegovy (semaglutide), opening the door to even more patients taking it. The “Wegovy pill”—cheaper than the ...
As the celebrations for the end of 2025 gathered pace, the FDA delivered a year-end blow to Corcept Therapeutics with a ...
Drug major Alkem Laboratories Limited has received a key regulatory clearance from the Subject Expert Committee (SEC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback